Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
J Neuroendocrinol ; 19(7): 499-510, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17532796

ABSTRACT

Mice with a deletion of the hypothalamic basic helix-loop-helix transcription factor Nhlh2 display adult onset obesity, implicating Nhlh2 in the neuronal circuits regulating energy availability. Nhlh2 colocalises with the hypothalamic thyrotrophin-releasing hormone (TRH) neurones in the paraventricular nucleus (PVN) and pro-opiomelanocortin (POMC) neurones in the arcuate nucleus. We show that Nhlh2 expression is significantly reduced in response to 24-h food deprivation in the arcuate nucleus, PVN, lateral hypothalamus, ventromedial hypothalamus (VMH) and dorsomedial hypothalamus (DMH). Food intake for 2 h following deprivation stimulates Nhlh2 expression in the arcuate nucleus and the PVN, and leptin injection following deprivation results in increased Nhlh2 expression in the arcuate nucleus, PVN, lateral hypothalamus, VMH, and DMH. Hypothalamic Nhlh2 expression in response to leptin injection is maximal by 2 h. Following leptin injection, Nhlh2 mRNA colocalises in POMC neurones in the arcuate nucleus and TRH neurones in the PVN. Nhlh2 mRNA expression in POMC neurones in the arcuate nucleus and TRH neurones in the PVN is reduced with energy deprivation and is stimulated with food intake and leptin injection. Modulation of POMC expression in response to changes in energy availability is not affected in mice with a targeted deletion of Nhlh2. However, deletion of Nhlh2 does result in loss of normal TRH mRNA expression in mice exposed to food deprivation and leptin stimulation. These data implicate Nhlh2 as a regulatory target of the leptin-mediated energy availability network of the hypothalamus, and TRH as a putative downstream target of Nhlh2.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Hypothalamus/metabolism , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Energy Metabolism , Female , In Situ Hybridization , Male , Mice , Pro-Opiomelanocortin/genetics , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Thyrotropin-Releasing Hormone/genetics
2.
Phys Rev E Stat Nonlin Soft Matter Phys ; 73(6 Pt 1): 061926, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16906883

ABSTRACT

In this work, we show a mathematical model for the angiogenesis by endothelial cells. We present the model at the level of partial differential equations, describing the spatiotemporal evolution of the cell population, the extracellular matrix macromolecules, the proteases, the tumor angiogenic factors, and the possible presence of inhibitors. We mainly focus, however, on a complementary, more physiologically realistic, hybrid approach in which the cells are treated as individual particles. We examine the model numerically in two-dimensional settings, discussing its comparison with experimental results.


Subject(s)
Models, Biological , Neoplasms/blood supply , Neovascularization, Pathologic/pathology , Angiogenesis Inhibitors/physiology , Angiogenic Proteins/physiology , Animals , Endothelial Cells/pathology , Endothelium, Vascular/pathology , Extracellular Matrix Proteins/physiology , Humans , Neovascularization, Pathologic/drug therapy , Peptide Hydrolases/physiology
3.
Anim Genet ; 37 Suppl 1: 24-7, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16886999

ABSTRACT

The control of energy balance is fundamental to adult animals and is necessary for weight gain/loss, reproductive capacity and general health. In mice, targeted deletion of the neuronal transcription factor Nhlh2 results in adult-onset obesity because of reduced exercise and infertility because of reduced sexual behaviour. Nhlh2 (NHLH2 for humans) is expressed in the hypothalamus, particularly in neurons that have been shown to regulate energy balance. We have cloned the bovine Nhlh2 gene (bNHLH2) and we have shown that bNHLH2 is also expressed in the hypothalamus. Phylogenetic analysis of Nhlh2 reveals that it is very highly conserved in humans, mice, chimps and cattle, and found in organisms with simpler nervous systems, including Caenorhabditis elegans and Drosophila. Using a cattle-human comparative map and online databases, we have evidence that bNHLH2 is located near a quantitative trait locus for marbling on bovine chromosome 3 between microsatellite markers BM723 and BMS963. Cloning of the bNHLH2 gene from Holstein cattle and a mixed breed individual and comparison with Hereford sequences shows that the gene is highly conserved among bovine breeds.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/physiology , Body Weight/genetics , Cattle/genetics , Amino Acid Sequence , Animals , Basic Helix-Loop-Helix Transcription Factors/metabolism , Brain/cytology , Brain/metabolism , Cattle/metabolism , Chromosome Mapping , Cloning, Molecular , Conserved Sequence , Molecular Sequence Data , Phylogeny , Quantitative Trait Loci , Sequence Alignment
4.
Clin Oncol (R Coll Radiol) ; 15(7): 435-9, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14570094

ABSTRACT

Ifosfamide (IFOS) is used in cancer treatment. Ifosfamide-induced encephalopathy (IIE) can result in treatment delay or discontinuation as well as morbidity and mortality. Cases using methylene blue (MB) in acute and prophylactic treatments are discussed. For acute use, marked central nervous system (CNS) improvement occurred within 24h of MB administration. For prophylactic use, the severity of the symptoms decreased significantly compared with previous treatment cycles, and enabled patients to continue further IFOS therapy. MB has potential use in both the acute treatment and prophylaxis of IIE.


Subject(s)
Antineoplastic Agents, Alkylating/adverse effects , Ifosfamide/adverse effects , Methylene Blue/therapeutic use , Neurotoxicity Syndromes/drug therapy , Neurotoxicity Syndromes/prevention & control , Adult , Aged , Female , Humans , Male
5.
Horm Behav ; 37(4): 284-98, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10860673

ABSTRACT

In the past few years, there has been exponential growth in our knowledge of genes that control food intake and metabolism. Most of this research has demonstrated either an increased or decreased expression of these "obesity genes" in response to changes in nutritional status. Ultimately, these changes reflect modifications in the rate of gene transcription, mRNA stability, translation initiation, or posttranslational processing. Few laboratories have examined specifically which of these molecular mechanisms are responsible for obesity gene regulation, and thus, the field is wide open for exploration. In addition, it is possible that some forms of human obesity may be caused by inherited mutations in transcription factors or other regulatory molecules rather than base pair mutations in the obesity genes themselves. This article focuses on the regulation of the leptin receptor, NPY, and POMC genes, and explores what is known about the regulation of these obesity genes in response to food intake or changes in body fat stores. Connections between regulation of these genes and some inherited forms of human obesity are made.


Subject(s)
Carrier Proteins/biosynthesis , Carrier Proteins/genetics , Gene Expression Regulation/genetics , Gene Expression Regulation/physiology , Neuropeptide Y/biosynthesis , Neuropeptide Y/genetics , Pro-Opiomelanocortin/biosynthesis , Pro-Opiomelanocortin/genetics , Protein Processing, Post-Translational/genetics , Protein Processing, Post-Translational/physiology , Receptors, Cell Surface , Receptors, Cytokine/biosynthesis , Animals , Base Sequence , Humans , Molecular Sequence Data , Receptors, Cytokine/genetics , Receptors, Leptin
6.
Nature ; 399(6737): 691-4, 1999 Jun 17.
Article in English | MEDLINE | ID: mdl-10385121

ABSTRACT

The establishment of the main body axis and the determination of left-right asymmetry are fundamental aspects of vertebrate embryonic development. A link between these processes has been revealed by the frequent finding of midline defects in humans with left-right anomalies. This association is also seen in a number of mutations in mouse and zebrafish, and in experimentally manipulated Xenopus embryos. However, the severity of laterality defects accompanying abnormal midline development varies, and the molecular basis for this variation is unknown. Here we show that mouse embryos lacking the early-response gene SIL have axial midline defects, a block in midline Sonic hedgehog (Shh) signalling and randomized cardiac looping. Comparison with Shh mutant embryos, which have axial defects but normal cardiac looping, indicates that the consequences of abnormal midline development for left-right patterning depend on the time of onset, duration and severity of disruption of the normal asymmetric patterns of expression of nodal, lefty-2 and Pitx2.


Subject(s)
Body Patterning/genetics , Embryonic and Fetal Development/genetics , Nuclear Proteins , Oncogene Proteins, Fusion , Proteins/genetics , Trans-Activators , Animals , Body Patterning/physiology , Embryo, Mammalian/abnormalities , Embryonic and Fetal Development/physiology , Gene Targeting , Heart/embryology , Hedgehog Proteins , Homeodomain Proteins/biosynthesis , Intracellular Signaling Peptides and Proteins , Left-Right Determination Factors , Mice , Mice, Nude , Mutagenesis , Neural Tube Defects/genetics , Nodal Protein , Paired Box Transcription Factors , Proteins/metabolism , Proteins/physiology , Signal Transduction , Stem Cells , Transcription Factors/biosynthesis , Transforming Growth Factor beta/biosynthesis , Homeobox Protein PITX2
7.
Nat Genet ; 15(4): 397-401, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9090387

ABSTRACT

The family of basic helix-loop-helix (bHLH) genes comprises transcription factors involved in many aspects of growth and development. We have previously described two bHLH transcription factors, Nhlh1 and Nhlh2 (originally named NSCL1 and NSCL2). The nucleotide and predicted protein sequences of Nhlh1 and Nhlh2 are homologous within their bHLH domain where there are only three conservative amino acid differences. During murine embryogenesis, Nhlh1 and Nhlh2 share an overlapping but distinct pattern of expression in the developing nervous system. To improve our understanding of the role of these genes during neurogenesis, we have generated mice containing targeted deletions of both genes and here describe our results for Nhlh2. Loss of Nhlh2 results in a disruption of the hypothalamic-pituitary axis in mice. Male Nhlh2-/- mice are microphallic, hypogonadal and infertile with alterations in circulating gonadotropins, a defect in spermatogenesis and a loss of instinctual male sexual behaviour. Female Nhlh2-/- mice reared alone are hypogonadal, but when reared in the presence of males, their ovaries and uteri develop normally and they are fertile. Both male and female homozygotes exhibit progressive adult-onset obesity. Nhlh2 is expressed in the ventral-medial and lateral hypothalamus, Rathke's pouch and in the anterior lobe of the adult pituitary. Our results support a role for Nhlh2 in the onset of puberty and the regulation of body weight metabolism.


Subject(s)
DNA-Binding Proteins/physiology , Hypogonadism/genetics , Obesity/genetics , Animals , Basic Helix-Loop-Helix Transcription Factors , DNA-Binding Proteins/genetics , Female , Fertility , Gene Expression Regulation, Developmental , Hypogonadism/complications , Hypothalamo-Hypophyseal System/chemistry , Hypothalamo-Hypophyseal System/embryology , Male , Mice , Mice, Knockout , Obesity/complications , Ovary/growth & development , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/embryology , RNA, Messenger/analysis , Sexual Behavior, Animal , Testis/growth & development
8.
J Cell Biol ; 122(2): 497-511, 1993 Jul.
Article in English | MEDLINE | ID: mdl-7686555

ABSTRACT

Thrombospondin-1 (TSP1) is a large modular matrix protein containing three identical disulfide-linked 180-kD chains that inhibits neovascularization in vivo (Good et al., 1990). To determine which of the structural motifs present in the 180-kD TSP1 polypeptide mediate the anti-angiogenic activity, a series of protease-generated fragments were tested using several in vitro and in vivo assays that reflect angiogenic activity. The majority of the anti-angiogenic activity of TSP1 resides in the central 70-kD stalk region which alone could block neovascularization induced by bFGF in the rat cornea in vivo and inhibit both migration in a modified Boyden chamber and [3H]thymidine incorporation stimulated by bFGF in cultured capillary endothelial cells. Although TSP1 has been shown to bind active TGF beta 1, this cytokine could not account for the inhibitory effects of the stalk region of TSP1 on cultured endothelial cells. Peptides and truncated molecules were used to further localize inhibitory activity to two domains of the central stalk, the procollagen homology region and the properdin-like type 1 repeats. Trimeric recombinant TSP1 containing NH2-terminal sequences truncated after the procollagen-like module inhibited endothelial cell migration in vitro and corneal neovascularization in vivo whereas trimeric molecules truncated before this domain were inactive as was the NH2-terminal heparin-binding domain that is present in both recombinant molecules. A series of peptides from the procollagen-like region, the smallest of which consisted of residues 303-309 of TSP1, inhibited angiogenesis in vivo in the rat cornea and the migration of endothelial cells in vitro. A 19-residue peptide containing these sequences blocked vessel formation in the granulation tissue invading a polyvinyl sponge implanted into the mouse. Nineteen residue peptides derived from two of the three type 1 repeats present in the intact TSP1 molecule blocked neovascularization in vivo in the rat cornea and inhibited the migration of cultured endothelial cells with ED50's of 0.6-7 microM. One of these peptides, containing residues 481-499 of TSP1, also inhibited vessel formation in granulation tissue invading sponges in vivo. These results suggest that the large TSP1 molecule employs at least two different structural domains and perhaps two different mechanisms to accomplish a single physiological function, the inhibition of neovascularization. The definition of short peptides from each of these domains that are able to block the angiogenic process may be of use in designing targeted inhibitors of the pathological neovascularization that underlies many diseases.


Subject(s)
Cell Adhesion Molecules/physiology , Endothelium, Vascular/cytology , Neovascularization, Pathologic , Peptide Fragments/pharmacology , Platelet Membrane Glycoproteins/physiology , Amino Acid Sequence , Animals , Cattle , Cell Adhesion Molecules/chemistry , Cell Movement/drug effects , Cells, Cultured , Cornea/blood supply , Endothelium, Vascular/drug effects , Fibroblast Growth Factor 2/pharmacology , Molecular Sequence Data , Peptide Fragments/chemistry , Platelet Membrane Glycoproteins/chemistry , Procollagen/chemistry , Properdin/chemistry , Rats , Thrombospondins , Thymidine/metabolism
9.
Schweiz Med Wochenschr ; 121(20): 764-6, 1991 May 18.
Article in German | MEDLINE | ID: mdl-2057743

ABSTRACT

A simplified 13C-urea breath test (UBT) for detection of Helicobacter pylori (Hp) infection was evaluated in 50 patients. Following upper gastrointestinal endoscopy the patients received 100 ml of a liquid test meal with 100 mg 13C-urea. Breath samples were obtained at baseline and 30 minutes respectively. The UBT was positive (difference of 13CO2 enrichment exceeding 5%) in 33/35 patients with culture-proven Hp infection and negative in 14/15 patients in whom microbiological culture, histology and a urease test (CLO-test) were negative. We conclude that in view of its high sensitivity (94%) and specificity (93%) the UBT is useful for rapid, non-invasive diagnosis of Hp infection.


Subject(s)
Breath Tests , Gastric Mucosa/microbiology , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Adult , Aged , Carbon Isotopes , Female , Helicobacter Infections/microbiology , Humans , Male , Middle Aged , Sensitivity and Specificity , Urea
10.
Proc Natl Acad Sci U S A ; 87(17): 6624-8, 1990 Sep.
Article in English | MEDLINE | ID: mdl-1697685

ABSTRACT

A secreted inhibitor of angiogenesis that is controlled by a tumor suppressor gene in hamster cells has been found to be similar to a fragment of the platelet and matrix protein thrombospondin. The two proteins were biochemically similar and immunologically crossreactive and could substitute for one another in two functional assays. Human thrombospondin inhibited neovascularization in vivo and endothelial cell migration in vitro, as does the hamster protein, gp140. gp140 sensitized smooth muscle cells to stimulation by epidermal growth factor, as does human thrombospondin. The thrombospondin gene has been localized on human chromosome 15. These results demonstrate a function for the ubiquitous adhesive glycoprotein thrombospondin that is likely to be important in the normal physiological down-regulation of neovascularization. In addition, they raise the possibility that thrombospondin may be one of a number of target molecules through which a tumor suppressor gene could act to restrain tumor growth.


Subject(s)
Glycoproteins/genetics , Membrane Glycoproteins/genetics , Neovascularization, Pathologic , Suppression, Genetic , Amino Acid Sequence , Animals , Blood Platelets/physiology , Cell Line , Chromosomes, Human, Pair 15 , Cricetinae , Glycoproteins/physiology , Humans , Membrane Glycoproteins/physiology , Molecular Sequence Data , Sequence Homology, Nucleic Acid , Thrombospondins
15.
J Med Chem ; 23(3): 300-4, 1980 Mar.
Article in English | MEDLINE | ID: mdl-7365745

ABSTRACT

Fourteen phosphorylated acetals and aldehydes were synthesized for testing in vitro as inhibitors or substrates of aldehyde oxidase, an enzyme involved in the conversion of aldophosphamide to inactive carboxyphosphamide, and for concurrent in vivo administration with cyclophosphamide to mice bearing L1210 ascites tumor cells. Five phosphorus derivatives gave Ki values of 0.1--0.3 mM compared to 0.03 mM for pyridoxal, as determined in aldehyde oxidase assays using N-methylnicotinamide as the substrate. The most active phosphorus inhibitor, ethyl phenyl(2-formylethyl)phosphinate (2b), and pyridoxal were further shown to give competitive and mixed inhibition, respectively. Three aldehydes, administered concurrently with cyclophosphamide, produced greater increases in life span of L1210-implanted mice than did pyridoxal. All four agents gave an average increase in life span greater than 50% over that shown by cyclophosphamide alone.


Subject(s)
Acetals/pharmacology , Aldehyde Oxidoreductases/antagonists & inhibitors , Aldehydes/pharmacology , Cyclophosphamide/pharmacology , Acetals/chemical synthesis , Aldehydes/chemical synthesis , Animals , Drug Synergism , Female , In Vitro Techniques , Kinetics , Leukemia L1210/drug therapy , Liver/enzymology , Mice , Rabbits , Structure-Activity Relationship
16.
J Med Chem ; 21(11): 1146-9, 1978 Nov.
Article in English | MEDLINE | ID: mdl-722720

ABSTRACT

A series of pyridine-2-carboxaldehyde N-oxide and pyridine-2-carboxaldehyde (thio)phosphoric hydrazones and two cupric chelates was synthesized. The hydrazones, chelates, and combinations of hydrazones and cupric chloride were tested against mice bearing P388 lymphocytic leukemia, Sarcoma 180, or Ehrlich carcinoma ascites cells. The effects of various structural modifications of the hydrazones on antineoplastic activity for this latter system were determined. In general, the pyridine-2-carboxaldehyde thiophosphoric monohydrazones containing P-phenyl or P-phenoxy substituents possessed the highest activity when concurrently administered with cupric ion, whereas the ligands themselves were inactive. Two of the compounds were prepared with P-hydroxyl groups to permit increased hydrophilicity. The ability of the hydrazones to chelate cupric, ferrous, and cobaltous salts was investigated, and discrepancies between determined and calculated log P values for three compounds are discussed.


Subject(s)
Antineoplastic Agents/chemical synthesis , Hydrazones/chemical synthesis , Animals , Carcinoma, Ehrlich Tumor/drug therapy , Chelating Agents , Female , Hydrazones/pharmacology , Leukemia, Experimental/drug therapy , Mice , Mice, Inbred DBA , Phosphorus , Sarcoma 180/drug therapy , Solubility , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...